Abcellera Biologics is trading 4.43% up at $14.39 as of 9:43 a.m. EST on October 6, 2026; no new company-specific announcement explaining the move was found. - The latest company news located was its October 1 notice that it will report third-quarter results on November 9. - Major U.S. indexes rose in the prior session, with the Nasdaq up more than 1% amid tech strength and risk appetite; available reporting does not directly link Abcellera Biologics’ gain to that move.